Overview

A Phase II Clinical Trial of KNP2002 (OM202JA)

Status:
Not yet recruiting

Trial end date:
2024-05-31

Target enrollment:
0

Participant gender:
All

Summary

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

KinoPharma Inc.

Criteria

Inclusion Criteria:

- Subjects aged 15 to 49 years old

- Subjects with common warts on the upper or lower limb

- Subjects who agree to contraception from obtaining consent to 4 weeks after the end of
administration

- Subjects who have given their voluntary written consent to participate in this
clinical trial

Exclusion Criteria:

- Subjects with 5 or more warts on the upper or lower limbs

- Subjects who are scheduled to undergo treatment such as physical therapy or
chemotherapy for warts

- Subjects with a history of allergy to topical skin preparations

- Subjects with a history of malignant tumor within 5 years before administration of
study drug

- Subjects with any of the following diseases: Malignant tumor; Serious heart disease;
Poorly controlled diabetes/hypertension

- Women who are pregnant, may become pregnant, or are breastfeeding